The findings, published Oct. 3 in Nature Methods, allow researchers to create sets of DNA variants in a single day for a few hundred dollars. Current methods take up to a week and cost tens of thousands of dollars.
“As a pediatric neurologist who does a lot of genetic studies of kids with developmental disabilities, I frequently will scan a patient’s whole genome for genetic variants,” said Christina Gurnett, MD, PhD, the study’s senior author and an associate professor of neurology and of pediatrics. “Sometimes I’ll find a known variant that causes a particular disease, but more often than not I find genetic variants that no one’s ever seen before, and those results are very hard to interpret.”
In the past, scientists tested the effect of genetic variants one by one, a laborious process. At a single point in the DNA sequence, they replaced the correct DNA letter – an A, T, C or G – with one of the other three options. Then, they translated that DNA sequence into a protein and evaluated whether the mutated protein behaved differently than the original one.
More recently, researchers have begun creating sets of hundreds of variants in which each letter in a particular DNA sequence is changed, and then testing the set all at once. Such studies have been limited, however, by the high cost of creating those sets.
Postdoctoral researcher Gabriel Haller, PhD, who was working in Gurnett’s lab, realized that he could harness common laboratory techniques and tools to create sets of DNA variants without the expensive equipment and reagents that drove up the price.
Haller copied a DNA sequence using the four standard DNA letters and a nonstandard letter known as inosine. Each copy of the sequence was identical except for one inosine, which was located at a random spot and served as a placeholder. Then, he replaced the inosine with one of the standard DNA letters, creating a single mutation in each copy of the sequence.
Gurnett and colleagues are applying this technique to genes associated with aortic aneurysms, a weakening and ballooning of the aortic wall that can be fatal. Over the long term, Gurnett envisions the creation of a catalog listing the effects of every possible variant. The speed and cheapness of the new technique make such a catalog possible.
“Then, when clinicians find a variant that’s never been seen before in one of these genes associated with aortic aneurysm, they can go through this catalog and say, ‘Yes, this mutation does have a negative effect on that protein, so it’s likely harmful’,” Gurnett said. “It would help them decide what to tell the patient. This would be one piece of the big interpretation puzzle for genetic mutations.”